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Background: Rett Syndrome (RTT) is a neurodevelopmental disease caused by the disruption of the MECP2 gene.
Several mouse models of RTT have been developed with Mecp2 disruptions. Although the mouse models are
widely used in RTT research, results obtained need to be validated in other species. Therefore, we performed these
studies to characterize phenotypes of a novel Mecp2−/Y rat model and compared them with the Mecp2tm1.1Bird
mouse model of RTT.
Methods: RTT-like phenotypes were systematically studied and compared between Mecp2−/Y rats and Mecp2−/Y
mice. In-cage conditions of the rats were monitored. Grip strength and spontaneous locomotion were used to
evaluate the motor function. Three-chamber test was performed to show autism-type behaviors. Breathing
activity was recorded with the plethysmograph. Individual neurons in the locus coeruleus (LC) were studied in
the whole-cell current clamp. The lifespan of the rats was determined with their survival time.
Results: Mecp2−/Y rats displayed growth retardation, malocclusion, and lack of movements, while hindlimb
clasping was not seen. They had weaker forelimb grip strength and a lower rate of locomotion than the WT
littermates. Defects in social interaction with other rats were obvious. Breathing frequency variation and apnea
in the null rats were significantly higher than in the WT. LC neurons in the null rats showed excessive firing
activity. A half of the null rats died in 2 months. Most of the RTT-like symptoms were comparable to those seen
in Mecp2−/Y mice, while some appeared more or less severe. The findings that most RTT-like symptoms exist in
the rat model with moderate variations and differences from the mouse models support the usefulness of both
Mecp2−/Y rodent models.
Conclusions: The novel Mecp2−/Y rat model recapitulated numerous RTT-like symptoms as Mecp2−/Y mouse
models did, which makes it a valuable alternative model in the RTT studies when the body size matters.
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Rett syndrome (RTT), a progressive neurodevelopmen-
tal disorder, affects predominantly female children
worldwide with an incidence of 1: 10,000 female births.
People with RTT display a developmental regression
which is characterized by a loss of acquired functions
such as speech and hand skills, and development of
stereotypic hand movements, gait apraxia, ataxia, and sei-
zures [1–3]. Breathing disorders are common including
hyperventilation, apnea, hyperpnoea, breath-holding, etc.* Correspondence: cjiang@gsu.edu
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death.
Defects in the X-linked gene MECP2 encoding the
methyl CpG binding protein 2 (MeCP2) known as a
transcriptional regulator, are identified in more than
90 % RTT patients. Mutations or altered expression of
Mecp2 in mice result in a spectrum of RTT-like neuro-
developmental disorders. Thus, several mouse models
of RTT have been developed and used in RTT studies
over the past years [8, 9]. For example, Mecp2tm1.1Bird,
Mecp2Jae, and Mecp2neoTam mouse models with exon 3
and/or 4 deletions in the Mecp2 are widely used in the
etiologic and therapeutic studies [9–11]. Other mouse
models with site-specific mutations, such as Mecp2T158A/y,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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years [12–14]. By using these mouse models, consider-
able progress has been made in the studies of the
neurobiological mechanisms underlying or associated
with RTT [15–19]. Mecp2tm1.1Bird mice, the most widely
used mouse model of RTT, show several phenotypes
similar to human patients with RTT, such as early
death, motor problems, and autistic behaviors, which
progressively worsen until death [20, 21]. Autonomic
dysfunction is another characteristic manifestation in-
cluding breathing disorders, cardiac arrhythmias, and
constipation [5, 22, 23]. Brainstem monoamine modula-
tory systems are involved. Electrophysiological and mo-
lecular biological studies in the Mecp2tm1.1Bird mouse
model suggest that neurons in the locus coeruleus (LC)
are defective, showing impaired neuronal activity, ab-
normal CO2 chemosensitivity and reduced expression
of enzymes for NE biosynthesis [19, 23–25].
Although the mouse models are widely used in RTT re-
search, results obtained need to be validated in other spe-
cies, which is particularly important when therapeutic
modalities are aimed to develop. Thus, studies on multiple
animal models of RTT are necessary and highly significant.
A novel Mecp2-knockout rat model, SD-Mecp2tm1sage rat,
has been developed recently (see below). The null rats had
a deletion of exon 4 in the Mecp2 leading to complete
elimination of the MeCP2 protein. Since the rat model
may provide useful information on RTT mechanisms and
treatments, we performed systematic studies of the RTT-
like symptoms identified previously in Mecp2−/Y mouse
models, and compared these RTT-like phenotypes with
those found in the male mouse model of RTT.
Methods
Animal
All animal experiments were conducted in accordance
with the National Institutes of Health (NIH) Guide for
the Care and Use of Laboratory Animals and were ap-
proved by the Georgia State University Institutional
Animal Care and Use Committee. The experiments
were performed on male Mecp2−/Y rats because the
male model offers a completely Mecp2-null condition
that is not always available in the female owing to ran-
dom X-chromosome inactivation [26, 27]. To breed
these males, the female heterozygous Mecp2+/− rat (SD-
Mecp2tm1sage, strain code: TGRA6090) from the sup-
plier company Horizon Discovery Group (Boyertown,
PA) were crossbred with the male Sprague-Dawley
wild-type rat (WT). The genotyping protocol from Sage
Labs in Horizon Discovery Group was used to identify
WT, heterozygous, and homozygous animals based on
a 71 bp deletion in the Mecp2 (Primer F: GCAGCAT-
CAGAAGGTGTTCA, Primer R: GACCTCAATGCT-
GACGGTTT). Female heterozygous mice (Genotype:Mecp2+/−; Strain name: B6.129P2(C)-Mecp2tm1.1Bird/J;
Stock number 003890) from Jackson Lab were crossbred
with male C57BL/6 mice to produce the Mecp2−/Y.
Body weight and in-cage conditions
Body weight of animals was measured and recorded
every week starting from postnatal day 7 (P1w) till death.
Teeth growth, food and water intake, movements, and
other body conditions were regularly checked as well.
Overly grown incisors that affected the food intake were
monitored and trimmed by the veterinarian weekly.
Grip strength
During the experiment, an animal was lifted by the tail,
and their forelimbs were allowed to grasp the metal
mesh fixed to a force-electricity transducer (CB Sci-
ences, Inc., Milford, MA). The animal was then gently
pulled upward while it grasped the mesh (10 mm ×
10 mm) with both forelimbs. The maximal force reached
immediately before it released the mesh was taken as the
grip strength. Signals were amplified, collected with the
Clampex 9 software, and stored in a computer. Com-
parison between rats and mice was done in animals aged
5–6 weeks.
Spontaneous locomotion test
Locomotion activity of male rats aged 4–5 weeks was
tested in a test chamber made of white plexiglass boards
(80 cm × 80 cm × 30 cm). The arenas were divided into
10 cm × 10 cm squares (n = 64) by drawing thin black
lines on the floor. The locomotion apparatus for male
mice aged 5–6 weeks was constructed with the same
material in size 50 cm × 50 cm × 30 cm with 10 cm ×
10 cm square lines. Animals were carried to the test
room in their home cages and habituated for 30 min be-
fore the locomotion test. Each tested animal was placed
in a center of the box and observed for 5 min. Each trail
was recorded with a video camera. Measures of square
crosses (all four paws cross) were obtained from the
video record. After the test, the apparatus was thor-
oughly cleaned using 70 % ethanol and then H2O to
eliminate potential residual odors and contaminants.
Three-chamber test
WT and Mecp2−/Y male rats, aged 4-5 weeks, were
tested in a three-chambered apparatus (90 cm × 60 cm ×
30 cm), where three chambers (30 cm × 60 cm × 30 cm
each) were separated by two transparent plexiglass walls
with an opening in each wall. Two buckets (12 cm in
diameter × 20 cm in height) made of 1 cm × 1 cm metal
mesh were placed in the center of the two-side cham-
bers. Similarly, mice aged 6–7 weeks were tested in an
apparatus with three 20 cm × 30 cm × 40 cm chambers.
The buckets and the metal mesh were 1/3 smaller in
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for 30 min habituation to its environment. A three-step
procedure was performed. First, the tested animal was
placed in the center chamber, and allowed to freely
move over all three chambers for 10 min. The time
spent in each chamber was recorded with a video cam-
era. Second, sociability was tested, in which a male in-
truder (Animal 1) in one mesh bucket was introduced to
one of the side chambers randomly, while the other
bucket was kept empty. The test animal was allowed to
explore both the chambers for 10 min with the total
time spent in the chamber measured. The intruder was
randomly assigned in one of the side chambers to avoid
the side bias. Lastly, the social novelty was tested by
switching the familiar intruder into the other chamber
and introducing a novel male intruder (Animal 2) to the
chamber. The tested animal was monitored for 10 min
as well. The time spent in each side chamber was mea-
sured. The apparatus was thoroughly cleaned between
trails using 70 % ethanol and H2O. All behavior tests
were performed during the light cycle (10 am to 7 pm).
Plethysmograph Recording
Breathing activities of awake rats were recorded with a
~1100-ml plethysmograph chamber. The individual
animal was kept in the plethysmograph chamber with
air ventilation at a rate of ~1000 ml/min. After at least
20 min adaptation, breathing activity was recorded
continuously for 20 min as the barometrical changes
between the plethysmograph chamber and the refer-
ence chamber with a force-electricity transducer
(Emka, Oxford, UK). The signal was amplified and re-
corded with AxoScope 10.3 software in a computer.
The data was analyzed with Clampfit 10.3 software.
Apnea rate and respiratory frequency variation were
measured. Apnea was considered only if the inspiration
interval was twice longer than the previous breathing.
Breathing frequency variation was defined as the stand-
ard deviation (SD) of the breathing frequency divided
by their arithmetic mean. The SD and arithmetic mean
were measured from ~200 successive breathing events.
Electrophysiology
The electrophysiological experiments were done as we
described previously [24]. In brief, experimental rats or
mice were decapitated after deep anesthesia with inhal-
ation of saturated isoflurane. The brainstem was ob-
tained and immediately placed in an ice-cold and
sucrose-rich cutting (in mM) solution containing 220 su-
crose, 33 NaHCO3, 1.9 KCl, 6 MgCl2, 1.2 NaH2PO4, 0.5
CaCl2, and 10 D-glucose. The solution was bubbled with
95 % O2—5 % CO2 (pH 7. 40). Transverse pontine sec-
tions (150–300 μm) containing the LC were obtained by
using a vibratome sectioning system and then recoveredat 33 °C for 60 min in normal artificial cerebrospinal
fluid (aCSF) (in mM) solution containing 124 NaCl, 26
NaHCO3, 3 KCl, 2 MgCl2, 1.3 NaH2PO4, 2 CaCl2, and
10 D-glucose. The brain slices were kept at room
temperature before usage. At recording, the slices were
perfused with oxygenated aCSF at a rate of 2 ml/min and
maintained at 34 °C in a recording chamber by a dual
automatic temperature control (Warner Instruments).
Whole-cell current clamp was performed on LC neu-
rons in the brain slices. Patch pipettes with a resistance
of 3–5 MΩ were prepared with Sutter pipette puller
(Model P-97, Novato, CA). Only were the neurons with
membrane potential less than −40 mV and action poten-
tial larger than 65 mV accepted for further experiments.
The pipette solution (in mM) contained 130 K gluco-
nate, 10 KCl, 10 HEPES, 2 Mg-ATP, 0.4 EGTA, and 0.3
Na-GTP (pH 7. 3). The bath solution was normal aCSF
bubbled with 95 % O2 balanced with 5 % CO2 (pH 7.
40). Recorded signals were amplified with an amplifier
Axopatch 200B (Molecular Devices, Union City, CA),
digitized at 10 kHz, filtered at 2 kHz, and collected with
the Clampex 8.2 data acquisition software (Molecular
Devices).
Lifespan
WT and Mecp2−/Y animals were randomly selected from
litters. Their lifespan were monitored. Death date of
each group was recorded. Both in-cage death and the
cases reach humane endpoint determined by the animal
facility at Georgia State University were counted. One
outlier at each end was removed from the data analysis
to minimize the data variation.
Randomization/double blind
The intruders used in the three-chamber test were ran-
domly selected from same species WT animals, and
randomly placed into one of the side chambers in the
sociability session. All the behavior experiments, in-
cluding motor function, social behavior, and breathing
activity were done double-blindly by two to three people.
All patch experiments were done double-blindly by three
people.
Data analysis
Data are presented as means ± SE. Student’s t test was
used to perform the statistical analysis. Difference was
considered significant when P ≤ 0.05 with degree of free-
dom (df ) shown.
Results
General RTT features
Mutation of the Mecp2 gene in rats caused several de-
velopmental abnormalities. Some of the abnormalities
have previously been identified in Mecp2−/Y mice, and
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The body weight of Mecp2−/Y rats was monitored every
week starting from postnatal day 7 (P7) till death. In
comparison to their WT littermates, Mecp2−/Y rats had
a much smaller body size and lower body weight. When
the body weight was compared between Mecp2−/Y and
WT rats, significant difference was observed in week 4
(75.6 ± 16.6 g in 18 Mecp2−/Y rats vs 90.3 ± 14.8 g in 20
WT; P = 0.004, df = 41, t = −3.057), and the difference in-
creased with growth (Fig. 1a, b). In addition, adult
Mecp2−/Y rats showed prolapsed penis (Fig. 1c) and se-
vere malocclusion (overgrowth of incisor teeth and mis-
placed midline, Fig. 1d). Hindlimb grasping, a typical
phonotype of Mecp2−/Y mice, was absent in Mecp2−/Y
rats (Fig. 1e). The Mecp2−/Y rats were also occasionally
observed with porphyrin (red tear), which was not seen
the WT littermates, and usually indicated sickness and
stress.
Muscle strength and locomotion
People with RTT have defects in motor functions, some of
which have been found in Mecp2−/Y mice. Similarly,
Mecp2−/Y rats showed fewer movements than their WT
littermates. Hence, we examined the motor function with
grip strength test and the observation of spontaneousFig. 1 General abnormalities of Mecp2−/Y rats. a Body weight of Mecp2−/Y r
difference became larger with growth (***P < 0.001, **P < 0.01; Student’s t t
(c), and malocclusion (d). e Typical hindlimb grasping seen in Mecp2−/Y miclocomotion. Grip strength of the forelimbs was moni-
tored weekly in 14 Mecp2−/Y rats and 19 WT rats. The
Mecp2−/Y rats showed a significant decrease in muscle
strength starting in 4 weeks after birth (P4w), and
remained significantly lower thereafter than that of the
WT (Fig. 2a). The maximum grip strength was reached
in P7w in null rats. In comparison, the grip strength of
WT rats continued to increase with growth.
When the grip strength was compared in P6w, the
muscle strength of both Mecp2−/Y rats and mice was
significantly lower than that of their WT littermates
(Fig. 2b). Because of the body size, rats were much
stronger than mice. We thus normalized the grip
strength to the WT in each group. After normalization,
similar reductions in the muscle strength were ob-
served in both Mecp2−/Y rats (by 29 % of the WT value)
and Mecp2−/Y mice (by 34 %) with no statistical differ-
ence found between species (Fig. 2c).
The spontaneous movement was measured with trav-
eling distance to indicate locomotor activity. A rat was
placed in the center of an enclosure and allowed to ex-
plore around for 10 min. The number of the squares
crossed by the rat was counted and recorded as locomo-
tion activity (squares crossed per min). The less square
traveling, the lower locomotor activity. The locomotionats was significantly lower than that of WT littermates at P4w, and the
est). Mecp2−/Y rats also showed growth retardation (b), prolapsed penis
e was not observed in Mecp2−/Y rats
Fig. 2 Reduced muscle strength and locomotor activity. a Mecp2−/Y rats exhibited decreased forelimb grip strength compared to WT (***P <
0.001, **P < 0.01, *P < 0.05; Student’s t test). b In comparison to the WT, both Mecp2−/Y rats and mice showed a significant decrease in grip
strength (Student’s t test). c No statistical significance in the grip strength differences was found between species after normalization to the
WT levels. d, e Locomotor activity was also significantly reduced in Mecp2−/Y rodents. No statistical significance was found between species
either, although the null rats appeared to move less (Student’s t test)
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than the WT littermates (35.4 ± 3.1 squares/min in 9
WT mice vs 26.2 ± 2.4 squares/min in 9 Mecp2−/Y mice,
P = 0.031, df = 17, t = 2.367; 28.3 ± 3.3 squares/min in 12
WT rats vs 16.2 ± 3.3 squares/min in 11 Mecp2−/Y rats; P
= 0.016, df = 21, t = 2.609) (Fig. 2d). After normalization to
the WT level, Mecp2−/Y rats showed 43 % reduction in
locomotor activity, while Mecp2−/Y mice had 26 % reduc-
tion (Fig. 2e). The low locomotion activity of Mecp2−/Y
rats suggests that the Mecp2 disruption causes motor dys-
function in both rats and mice with similar severity.
Autism-like behavior
Another clinic manifestation of RTT is the autism-like
behavior that also occurs in Mecp2−/Y mice. Using the
three-chamber test, therefore, we studied the autism-
like behavior in Mecp2−/Y rats. During the tests, a rat
was placed in the middle chamber of the three-
compartmental box with an opening to each of the side
chambers. During the first 10-min habituation period,
rat preference to either side chamber was recorded asthe time spent in each chamber (Fig. 3a, b). Only the
animals showing no preference to either side of cham-
bers in the habituation time were used for further tests.
Then, sociability was tested in a three-chamber appar-
atus with two identical mental-mesh buckets introduced
to each side chamber. An intruder animal was randomly
placed in one of the buckets, and the other was kept
empty. The mesh bucket allowed the animal to have vis-
ual, olfactory, and auditory contact and exploration.
During these second 10-min tests, WT rodents spent
more time with their kinds than the empty chamber
(259.8 ± 24.5 s vs 183.1 ± 21.3 s in 10 WT mice, P =
0.045, df = 19, t = 2.156; 346.4 ± 41.9 s vs 142.4 ± 24.2 s
in 10 WT rats, P < 0.001, df = 19, t = -4.217) (Fig. 3c, d),
consistent with previous reports [28–30]. Such a prefer-
ence was not seen in both Mecp2−/Y rodents. Mecp2−/Y
rats spent less time in the intruder chamber than in the
empty one (99.2 ± 48.8 s with Animal 1 vs 169.5 ± 74.5 s
in empty; n = 11, P = 0.439, df = 21, t = 0.789), similar to
Mecp2−/Y mice (214.5 ± 50.4 s with Animal 1 vs 224.4 ±
53.0 s in empty; n = 8, P = 0.895, df = 15, t = −0.135)
Fig. 3 Social behavior defects of Mecp2−/Y rats. a, b The habituation time in side chambers had no significant difference in Mecp2−/Y animals and
WT littermates. c, d The time spending of both Mecp2−/Y animals in the intruder chamber (Animal 1) was more than in the empty bucket chamber
(Empty). e, f The animal preference disappeared in both Mecp2−/Y animals. Familiar animal is indicated as Animal 1, and unfamiliar animal is labeled as
Animal 2. (***P < 0.001, **P < 0.01, * P < 0.05; Student’s t test)
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ability was comparable between Mecp2−/Y rats and
mice.
The social novelty was tested during the last 10 min
when a novel stranger (Animal 2) in addition to the first
intruder (Animal 1 or familiar) was introduced to the
previously empty bucket. The time spent in either side
chambers was measured. Consistent with previous re-
ports [29, 30], the WT animals showed a clear tendency
of social novelty by spending a longer time with the
stranger animal than with the familiar one (363.4 ±
34.5 s with Animal 2 vs 140.4 ± 27.5 s with Animal 1 vs
in WT mice, P < 0.001, df = 19, t = 5.052; 395.4 ± 56.3 s
with Animal 2 vs 101.8 ± 28.1 s with Animal 1 in WT rats,
P = 0.002, df = 19, t = −4.666) (Fig. 3e, f ). Such a preference
disappeared in Mecp2−/Y animals (227.7 ± 63.1 s with Ani-
mal 1 vs 256.7 ± 55.3 s with Animal 2 in Mecp2−/Y mice,
P = 0.422, df = 15, t = 0.828; 250.1 ± 76.0 s with Animal 1
vs 171.8 ± 68.1 s with Animal 2 in Mecp2−/Y rats, P =
0.452, df = 21, t = 0.767) (Fig. 3e, f ). Therefore, the results
suggest that the Mecp2−/Y rats show the autism-like social
defects similarly toMecp2−/Y mice.
Breathing abnormality
People with RTT as well as the mouse models of RTT
show breathing abnormalities [4–7]. Thus, we measuredthe breathing activity using the plethysmography in con-
scious animals. Two most reliable breathing phenotypes,
apneas and breathing frequency variations, were ana-
lyzed as shown in several previous studies [23, 31]. High
apnea rate and breathing frequency variations were seen
in Mecp2−/Y rats. They started showing a significant dif-
ference from those in the WT rats in P4w, and deterio-
rated with growth (Fig. 4a–d). By P7w, the apnea rate
was raised to 49.3 ± 2.9 h−1 of Mecp2−/Y rats in compari-
son to 26.5 ± 2.7 h−1 of WT (Fig. 4c), and the breathing
variation increased to 0.21 ± 0.02 in 15 Mecp2−/Y rats
comparing to 0.09 ± 0.01 in 8 WT (Fig. 4d). The breath-
ing abnormalities of Mecp2−/Y rats were compared with
those in the Mecp2−/Y mice at the same age group (5–
7 weeks). Both Mecp2−/Y strains had severe breathing
problems in comparison to their WT littermates with a
higher apnea rate (22.8 ± 6.5 h–1 in 12 WT mice vs
107.0 ± 7.4 h–1 in 24 Mecp2−/Y mice, P < 0.001, df = 35,
t = -7.335; 19.7 ± 1.8 h–1 in 11 WT rats vs 44.8 ± 2.7 h–1
in 27 Mecp2−/Y rats, P < 0.001, df = 37, t = −5.784)
(Fig. 4e) and a higher respiratory frequency variation
(0.12 ± 0.02 in 14 WT mice vs 0.26 ± 0.02 in 25 Mecp2
−/Y mice, P < 0.001, df = 38, t = −6.184; 0.08 ± 0.01 in 11
WT rats vs 0.18 ± 0.02 in 27 Mecp2−/Y rats, P < 0.001,
df = 37, t = −4.454) (Fig. 4f ). However, the apnea rate
was significantly lower in Mecp2−/Y rats than in the
Fig. 4 Breathing abnormalities. a, b Abnormal breathing activity including apnea and irregular breathing was observed in Mecp2−/Y rats at P35
and P81. c, d Apnea rate and respiratory frequency variation were significantly more in Mecp2−/Y rats than in the WT (***P < 0.001, **P < 0.01,
*P < 0.05; Student’s t test). e–h the breathing abnormalities were compared between mouse and rat (***P < 0.001; Student’s t test). g The
apnea rate of Mecp2−/Y rats was significantly lower than that of the Mecp2−/Y mice after data normalization to the WT levels. h The severity of
breathing frequency variation was not significantly different between rats and mice
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(Fig. 4e, g), while the frequency variation had no signifi-
cant difference between species (Fig. 4f, h). These re-
sults suggest that the breathing abnormalities seem less
severe in Mecp2−/Y rats than in Mecp2−/Y mice.
Hyperexcitability of LC neurons
Several groups of brainstem neurons are involved in
breathing controls including those in the LC. Previous
studies indicate that the Mecp2 disruption in mice
causes hyperexcitability in LC neurons [19, 32]. To testwhether there is a change in LC neuronal excitability in
Mecp2−/Y rats, we studied the cells in brain slices. In
whole-cell current clamp, LC neurons in Mecp2−/Y rats
(P4w-P6w) showed spontaneous firing rate 3.0 ± 0.3 Hz,
which was significantly higher than the WT 1.9 ± 0.2 Hz
(Fig. 5a–c. P = 0.006, df = 34, t = −2.921 Student’s t test).
The firing rate of LC neurons in Mecp2−/Y rats was in-
creased by 54.0 ± 14.6 % over the WT level (Fig. 5c).
Similar results were found in Mecp2−/Y mouse model in
the same age range as well (Fig. 5d). There were no dif-
ferences in the membrane potential, input resistance,
Fig. 5 Increased excitability of LC neurons. a, b Typical recordings of spontaneous firing activity in WT and Mecp2−/Y rat LC neurons. c In
Mecp2−/Y rats, LC neurons showed a significant increase in firing frequency in comparison to the WT. d The ratio of increased spontaneous
firing rate, however, was similar between rats and mice. e, f No significant differences were found in membrane potential and resistance
between WT and Mecp2−/Y rats, which was similar as in the mice model. g, h In comparison to the WT, Mecp2−/Y rats showed more
hyperpolarized threshold of the action potential in LC neurons, whereas the amplitude was not altered. Similar results were found in the
mouse model (**P < 0.01,*P < 0.05; Student’s t test)
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WT rats (Fig. 5e–g), neither between rats and mice. In
Mecp2−/Y rats, the threshold of action potential was
shifted to significantly more hyperpolarizing potentials
from −34.4 ± 1.2 to −37.2 ± 0.8 mV (Fig. 5h), which ap-
peared to contribute to the increased firing activity of
LC neurons.Lifespan
These RTT-like symptoms may affect the lifespan of
rats. Therefore, we examined the survival time in the
novel Mecp2−/Y rat model of RTT. The death was deter-
mined by either in-cage death or the humane endpoint
determined by our school veterinarian. A total of 18 WT
males and 18 Mecp2−/Y rats were used in the studies,
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were removed. Figure 6a shows that Mecp2−/Y rats died
as early as at P45, and all died by P82. Only two out of
16 tested rats survived beyond 80 days. Similar results
were found in mice (not shown). In comparison, 50 %
of the Mecp2−/Y rats died at P63, while 50 % of the
Mecp2−/Y mice died at P52 (Fig. 6c). To compare these
two groups of animals, we performed the χ2 test, and
did not find any statistical difference in the ratio of sur-
vival vs death between these rats and mice at P52, nei-
ther at P63 (Fig. 6d, e).Discussion
RTT is a progressive neurodevelopmental disorder caused
mostly by different mutations in the MECP2 gene. The
disease affects females mainly. Male infants rarely survive
with pathogenic MECP2 variations, because knockout of
MECP2 gene causes lethal miscarriages and early death in
males [33, 34]. However, the male mice with Mecp2 dis-
ruption survive, and show reliable and consistent RTT-
like symptoms. This leads to wide uses of these mice in
RTT studies. Experimental approaches to the female
mouse models have limitations because of the X-
chromosome inactivation and the large symptomatic
variation among individuals. With the same consider-
ation, our experiments were performed on the Mecp2
−/Y male rats as well. This novel RTT rat model has a
71-bp deletion in exon 4 at 53900-53970 of the Mecp2
gene by Zinc Finger Nuclease technology. This results
in a fragment deletion as well as a shift of the open
reading frame leading to a complete knockout of
MeCP2 [35]. Consistently, our studies demonstrate thatFig. 6 Survival rate. a The survival time of Mecp2−/Y rats was plotted in com
after normalization of the initial rate to 1. c A half of Mecp2−/Y rats died at
survived, while about three fourth of the rats were still alive. e At P63 or th
were still alive. Despite these, no statistical significance was found betweenthe male Mecp2-null rats experience severe RTT-like
symptoms.
Recapitulation of RTT-like phenotypes in Mecp2−/Y rats
Many general RTT-like features have been recapitulated
in the rat model of RTT, including growth retardation,
malocclusion, lack of movement, and early death. The
Mecp2−/Y rats show weaker forelimb grip strength and
less locomotion activity than the WT littermates, which
are similar to those observed in their mouse counter-
parts. Defects in sociability and social novelty were seen
in these Mecp2−/Y rats. Breathing abnormalities of the
Mecp2−/Y rats including irregular respiratory rhythm and
high apnea rate resemble closely respiratory dysfunction
in RTT patients and mouse models. Besides, LC neurons
of Mecp2−/Y rats show excessive firing activity, which
has also been observed in the mouse models before. A
half of the Mecp2−/Y rats died in 2 months. These RTT-
like symptoms observed in Mecp2−/Y rats thus are com-
parable to those seen in Mecp2−/Y mice [23, 28, 31].
Consistently, a recent study has demonstrated that the
Mecp2−/+ rats had similarly impaired auditory responses
as Mecp2 heterozygous female mice [35, 36], which is
seen in RTT patients as well [37]. Therefore, Mecp2−/Y
rats recapitulated most of the RTT-like symptoms, mak-
ing them a quality RTT model.
Onset time of RTT-like symptoms in Mecp2−/Y rats
RTT is characterized by relatively normal development
at the earlier stage of life. The asymptomatic time win-
dow is usually from birth to 6 months in humans with
RTT [38]. In mouse models, the onset time and the dis-
ease progression vary depending on the nature of Mecp2parison to WT littermates (n = 16). b The 50 % lethality was shown
P63, while 50 % Mecp2−/Y mice dies at P52. d At P52, 50 % mice were
e half survival age of Mecp2−/Y rats, only about one third of the mice
rats and mice (d, e)
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agree that Mecp2−/Y mice have no overt RTT symptoms
within the first 3 weeks of life. After that, the null mice
show rapid development and progression of RTT-like
symptoms. Growth retardation can be observed in P4w
[21, 39, 40]. Locomotor problems appear in P3w-P4w in
mouse models [10, 41]. Social defects are observed as
early as 4 weeks after birth in mice [42]. Breathing dis-
turbances occur in null mice at P3w-P4w [21]. In Mecp2
−/Y rats, these RTT-like symptoms also take place as
early as 3 weeks, and become obvious at P4w. Thus, the
onset time of the RTT-like phenotypes in the Mecp2−/Y
rats is comparable to that in Mecp2−/Y mice.
Defects of neuronal activity in Mecp2−/Y rats
LC neurons are the predominant source of noradrener-
gic modulation in the CNS [43, 44]. They project to vari-
ous regions in the brain, including the forebrain,
diencephalon, brainstem, cerebellum, and even the
spinal cord [43, 44]. Defects of LC neurons lead to dys-
function of autonomic nervous system, consistent with
the characteristic RTT-like symptoms. In Mecp2−/Y
mice, the LC neurons show electrophysiological defects
as increased neuronal firing activity, which is likely to be
a result of the impaired intrinsic membrane properties
and the deficiency in GABA-ergic inhibition [24, 25, 45].
Similar hyperexcitability of LC neurons is found in
Mecp2−/Y rats, suggesting that the Mecp2−/Y rats may
develop similar neuronal defects as Mecp2−/Y mice. In
addition to LC neurons, neuronal hyperexcitability is
seen in neurons in the hippocampus, neocortex and
other brainstem areas in Mecp2−/Y mice, which contrib-
utes to the defects in motor function, cognition, sleep,
and other autistic features [17, 46, 47]. These, though
still unclear, may occur in other neurons of the Mecp2
−/Y rats.
Symptomatic difference between Mecp2−/Y rats and mice
Although the Mecp2−/Y rat model has many similarities
to the Mecp2−/Y mouse models, our studies suggest that
the former is not a complete replica of the latter. Indeed,
some RTT-like phenotypes are quite different between
rat and mouse models. All Mecp2−/Y rats displayed mal-
occlusion that appears more severe than null mice. The
incisor teeth overly grow which may be due to the re-
duction of the central command of chewing activity, sick
jaw muscles, and/or abnormal propriosensation in the
transgenic rats. Besides, the Mecp2−/Y rats had a propor-
tional reduction in body size compared to their WT lit-
termates, which seems more obvious than that seen in
Mecp2−/Y mice. Another difference found in over a half
of Mecp2−/Y rats is the penile prolapse. This symptom
has been reported in transgenic mice with neurodegen-
eration [48] but not in Mecp2−/Y mice. This oftenhinders the penis from retraction even with the lubrica-
tion treatment, which contributes to the humane end-
point of the rats. Mecp2−/Y rats did not show the typical
hindlimb grasping as Mecp2−/Y mice did [49]. In the
three-chamber test, old (P7w) Mecp2−/Y rats barely
switched between each chamber due to the poor loco-
motor activity, which has caused rejection of them from
social behavioral tests. In contrast, mice do not show
such age-dependent deterioration in locomotor activity
as defects in social behaviors are reported at various ages
from P4w to P12w in different mouse models [21, 50].
Furthermore, breathing abnormalities appear less severe
in Mecp2−/Y rats than in Mecp2−/Y mice. This may be re-
lated to the low breathing frequency of the rats. In gen-
eral, these symptomatic differences between Mecp2−/Y
mice and Mecp2−/Y rats are rather moderate and quanti-
tative rather than qualitative.
Advantages and the applications of the RTT rat model
The rat model has several potentials in RTT studies. The
understanding of the link between RTT phenotypes and
the neuronal cellular and network mechanisms relies on
in-vivo approaches that are still difficult to be fulfilled in
mice. The larger body size of rats may satisfy the re-
quirement for the in-vivo studies. The larger body size
may benefit certain tests that need repetitive and timely
samplings, such as measurement of blood gases, electro-
lytes and hormonal levels in circulation blood and cere-
brospinal fluid, monitoring of systemic physiological
parameters and EEG recordings. The richness of the so-
cial and communication repertoire of rats may also
benefit the behavior studies, such as cognitive processes,
anxiety, social acoustic memory, cooperative behaviors
and auditory responses [51]. Most importantly, studies
on multiple animal models can benefit RTT research, es-
pecially when therapeutic agents are to be developed.
Conclusions
Our studies indicate that the novel Mecp2−/Y rats recap-
itulate numerous RTT-like symptoms as the Mecp2−/Y
mouse model do. The RTT rat model, as a valuable
model in the studies of RTT, may provide a useful alter-
native in RTT studies when body size is considered to be
a critical factor.
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